DK121788D0 - Il-6, fremgangsmaade til dets fremstilling samt dets anvendelse - Google Patents

Il-6, fremgangsmaade til dets fremstilling samt dets anvendelse

Info

Publication number
DK121788D0
DK121788D0 DK121788A DK121788A DK121788D0 DK 121788 D0 DK121788 D0 DK 121788D0 DK 121788 A DK121788 A DK 121788A DK 121788 A DK121788 A DK 121788A DK 121788 D0 DK121788 D0 DK 121788D0
Authority
DK
Denmark
Prior art keywords
procedure
manufacturing
hematopoietins
deficiencies
peptide
Prior art date
Application number
DK121788A
Other languages
English (en)
Other versions
DK121788A (da
DK173279B1 (da
Inventor
Steven C Clark
Gordon G Wong
Paul Schendel
John Mccoy
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27367237&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK121788(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genetics Inst filed Critical Genetics Inst
Publication of DK121788A publication Critical patent/DK121788A/da
Publication of DK121788D0 publication Critical patent/DK121788D0/da
Application granted granted Critical
Publication of DK173279B1 publication Critical patent/DK173279B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
DK198801217A 1986-07-08 1988-03-07 Rekombinant IL-6, fremgangsmåde til dets fremstilling og vektor til brug ved denne fremstilling samt dets anvendelse DK173279B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US88320786A 1986-07-08 1986-07-08
US88320786 1986-07-08
US88590586A 1986-07-15 1986-07-15
US88590586 1986-07-15
US4795787A 1987-05-08 1987-05-08
US4795787 1987-05-08
PCT/US1987/001611 WO1988000206A1 (en) 1986-07-08 1987-07-07 Production and use of il-6
US8701611 1987-07-07

Publications (3)

Publication Number Publication Date
DK121788A DK121788A (da) 1988-03-07
DK121788D0 true DK121788D0 (da) 1988-03-07
DK173279B1 DK173279B1 (da) 2000-06-05

Family

ID=27367237

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198801217A DK173279B1 (da) 1986-07-08 1988-03-07 Rekombinant IL-6, fremgangsmåde til dets fremstilling og vektor til brug ved denne fremstilling samt dets anvendelse

Country Status (18)

Country Link
EP (2) EP0574955B1 (da)
JP (1) JP2664698B2 (da)
KR (1) KR960013601B1 (da)
AT (2) ATE143811T1 (da)
AU (1) AU615630B2 (da)
CA (1) CA1341355C (da)
DE (2) DE3751922T2 (da)
DK (1) DK173279B1 (da)
ES (1) ES2006776A6 (da)
GR (1) GR871027B (da)
IE (1) IE67035B1 (da)
IL (1) IL83137A (da)
MY (1) MY102865A (da)
NO (1) NO176665C (da)
PL (1) PL159182B1 (da)
PT (1) PT85285B (da)
SK (1) SK279144B6 (da)
WO (1) WO1988000206A1 (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554513A (en) * 1979-11-21 1996-09-10 Yeda Research & Development Co. Ltd. Production of recombinant human interferon-beta2
US5510472A (en) * 1979-11-21 1996-04-23 Yeda Research And Development Co. Ltd. Production of recombinant human interferon-beta2
EP0645452A1 (en) * 1985-10-14 1995-03-29 Yeda Research And Development Co. Ltd. Human interferon-beta 2A and interfeon-beta 2B, vectors containing genes coding for said interferons, cell lines producing same and use of said interferons as pharmaceuticals
JP2648860B2 (ja) * 1986-05-08 1997-09-03 イエダ リサーチ アンド デベロップメント コンパニー リミテッド ヒトインターフエロン−β２Ａ及びヒトインターフエロン−β２Ｂ、該インターフエロンをコードする遺伝子を含むベクター、該インターフエロンを産生するセルライン及び該インターフエロンの医薬品としての用途
EP0585957A1 (en) * 1986-08-06 1994-03-09 Ajinomoto Co., Inc. Recombinant B-cell differentiation factor
JP2676336B2 (ja) * 1986-08-06 1997-11-12 忠三 岸本 ヒトｂ細胞分化因子の遺伝子
JPS6356291A (ja) * 1986-08-27 1988-03-10 Chuzo Kishimoto リコンビナントｂｃｄｆ
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
CA1341588C (en) * 1988-01-26 2009-01-06 Michel Revel Human ifn-beta2/i1-6, its purification and use
IL85204A0 (en) * 1988-01-26 1988-07-31 Yeda Res & Dev Recombinant human interferon beta2,its preparation and pharmaceutical compositions comprising it
HUT52962A (en) * 1988-03-04 1990-09-28 Sandoz Ag Process for production of medical compositions eliminating bone-absorption and promoting forming of bones
JPH022353A (ja) * 1988-03-10 1990-01-08 Tosoh Corp ヒトｂ細胞分化因子の製造法
JPH022354A (ja) * 1988-03-31 1990-01-08 Tosoh Corp ヒトｂ細胞分化因子の製造法
GB2217327B (en) * 1988-04-12 1992-01-29 British Bio Technology Synthetic interleukin-6 gene
US5646015A (en) * 1988-08-31 1997-07-08 Astra Ab Excretion of heterologous proteins from E. coli
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
US5271931A (en) * 1988-09-14 1993-12-21 The Scripps Research Institute Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6
JPH0372429A (ja) * 1988-10-07 1991-03-27 Chugai Pharmaceut Co Ltd 血小板減少症の治療剤
US5811523A (en) 1988-11-10 1998-09-22 Trinchieri; Giorgio Antibodies to natural killer stimulatory factor
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤
JPH0331215A (ja) * 1989-06-27 1991-02-12 Ajinomoto Co Inc 制癌療法支持剤
DE3939706C1 (da) * 1989-12-01 1991-03-21 Centre Regional De Transfusion Sanguine, Besancon, Fr
JPH04218000A (ja) * 1990-02-13 1992-08-07 Kirin Amgen Inc 修飾ポリペプチド
EP0547223B1 (en) * 1990-08-31 1996-10-16 Santen Pharmaceutical Co., Ltd. Remedy for corneal damages
ATE210150T1 (de) * 1991-04-18 2001-12-15 Toray Industries Verfahren zur herstellung von interleukin-6 zusammensetzungen
US5641868A (en) * 1991-04-18 1997-06-24 Toray Industries, Inc. Interlekin-6 compositions, and a production process thereof
ZA924674B (en) * 1991-07-02 1993-04-28 Imclone Systems Inc Cysteine depleted il-6 mutein
US5338833A (en) * 1992-07-23 1994-08-16 The University Of North Carolina At Chapel Hill Carboxy terminal IL-6 muteins
US5338834A (en) * 1993-01-26 1994-08-16 Allelix Biopharmaceuticals Inc. Ultrapure human interleukin-6
EP0661057A4 (en) * 1993-06-08 1997-09-03 Ajinomoto Kk ACCELERATOR OF THE PROLIFERATION OF HEMATOPIETIC CELLS.
US5599536A (en) * 1993-12-13 1997-02-04 Sandoz Ltd. Method for suppressing the acute phase response in a patient receiving IL-6 therapy
US5578301A (en) * 1993-12-14 1996-11-26 Sandoz Ltd. Method for using GM-CSF to reduce the acute phase response in a patient being administered IL-6 therapy
US5641657A (en) * 1994-05-19 1997-06-24 Human Genome Sciences, Inc. DNA encoding an interleukin-6 splice variant
EP0721780A3 (en) * 1994-12-16 1997-12-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Agent for promoting platelet and/or leukocyte production
US7968696B1 (en) * 1996-07-19 2011-06-28 Behring Diagnostics Gmbh Viral interleukin-6
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
US7479540B1 (en) 2003-12-22 2009-01-20 Chandan Prasad Adipomodulin and related molecules and methods
CA2597795A1 (en) * 2005-02-15 2006-08-24 Apollo Life Sciences Limited A molecule and chimeric molecules thereof
ES2302402B1 (es) 2005-06-16 2009-05-08 Proyecto De Biomedicina Cima, S.L. Uso de una citoquina de la familia de interleuquina-6 en la preparacion de una composicion para administracion combinada con interferon-alfa.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4675285A (en) * 1984-09-19 1987-06-23 Genetics Institute, Inc. Method for identification and isolation of DNA encoding a desired protein
EP0645452A1 (en) * 1985-10-14 1995-03-29 Yeda Research And Development Co. Ltd. Human interferon-beta 2A and interfeon-beta 2B, vectors containing genes coding for said interferons, cell lines producing same and use of said interferons as pharmaceuticals
EP0585957A1 (en) * 1986-08-06 1994-03-09 Ajinomoto Co., Inc. Recombinant B-cell differentiation factor

Also Published As

Publication number Publication date
JPH01503354A (ja) 1989-11-16
IL83137A (en) 1995-05-26
MY102865A (en) 1993-03-31
DE3751922D1 (de) 1996-11-14
EP0574955B1 (en) 1996-10-09
GR871027B (en) 1987-11-02
PT85285A (en) 1987-08-01
KR960013601B1 (ko) 1996-10-09
ES2006776A6 (es) 1989-05-16
DE3751406T2 (de) 1995-12-21
EP0316319A4 (en) 1989-08-09
ATE124959T1 (de) 1995-07-15
IE871726L (en) 1988-01-08
EP0316319A1 (en) 1989-05-24
ATE143811T1 (de) 1996-10-15
PL159182B1 (pl) 1992-11-30
JP2664698B2 (ja) 1997-10-15
SK515087A3 (en) 1998-07-08
DK121788A (da) 1988-03-07
EP0316319B1 (en) 1995-07-12
DE3751406D1 (de) 1995-08-17
DK173279B1 (da) 2000-06-05
DE3751922T2 (de) 1997-04-03
PT85285B (pt) 1990-03-30
NO880929L (no) 1988-03-02
IE67035B1 (en) 1996-02-21
PL266680A1 (en) 1988-07-07
AU615630B2 (en) 1991-10-10
CA1341355C (en) 2002-04-09
WO1988000206A1 (en) 1988-01-14
EP0574955A1 (en) 1993-12-22
KR880701736A (ko) 1988-11-04
NO176665C (no) 1995-05-10
NO176665B (no) 1995-01-30
AU7696287A (en) 1988-01-29
SK279144B6 (sk) 1998-07-08
NO880929D0 (no) 1988-03-02

Similar Documents

Publication Publication Date Title
DK121788A (da) Il-6, fremgangsmaade til dets fremstilling samt dets anvendelse
PH25120A (en) Replicable expression vehicle and process of preparation thereof
FI864016A (fi) Med rekombinant-dna-teknik erhaollen kolonistimulerande faktor-1.
DK224587D0 (da) Ekstracellulaer superoxiddismutase (ec-sod), dna-fragment, der indkoder ec-sod, fremgangsmaade til fremstilling af ec-sod samt anvendelse af ec-sod
FI943750A0 (fi) Menetelmä nekroositekijän valmistamiseksi
ES2052580T3 (es) Nuevas formas de factor-1 estimulante de colonias.
DE69022778T2 (de) Zellkultursubstrat, Bioreaktor mit Zellkultursubstrat und therapeutische Vorrichtung vom extrakorporalen Umlauftyp.
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
DK509985A (da) Antibiotisk polypeptid, fremgangsmaade til dets fremstilling samt dets anvendelse
ATE127842T1 (de) Megakaryocytopoietin, seine herstellung und benutzung.
ZA857721B (en) Process for treatment of rheumatic diseases
FI851365L (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
EP0248583A3 (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
FI885025A (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
ATE92333T1 (de) Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon.
NO864742D0 (no) Dna-sekvens som koder for human vevsplasminogenaktivator, rekombinant dna-sekvens, vertcelle transformert med denne samt fremgangsmaate for fremstilling av plasminogenaktivatoren.
DE3779974T2 (de) Abrasive formkoerper mit kubischem bornitrid.
DK131989D0 (da) Dna-sekvens, der koder for protein pp15; samt genteknologisk fremstillet pp15 og dets anvendelse
EP0278715A3 (en) Use of human gamma interferon for treatment of basal cell carcinoma
SU1475058A1 (ru) Днище гидросамолета

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK